Caroline J Witton Warner
Caroline J Witton Warner
Research Scientist, Agilent
Verified email at
Cited by
Cited by
Expression of the HER1–4 family of receptor tyrosine kinases in breast cancer
CJ Witton, JR Reeves, JJ Going, TG Cooke, JMS Bartlett
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2003
AKT activation predicts outcome in breast cancer patients treated with tamoxifen
T Kirkegaard, CJ Witton, LM McGlynn, SM Tovey, B Dunne, A Lyon, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2005
Gene amplifications associated with the development of hormone-resistant prostate cancer
J Edwards, NS Krishna, CJ Witton, JMS Bartlett
Clinical cancer research 9 (14), 5271-5281, 2003
Outcome and Human Epithelial Growth Factor Receptor (HER) 1-4 status in invasive breast carcinomas with proliferation indices evaluated using bromodeoxyuridine (BrdU) labelling
SM Tovey, CJ Witton, JMS Bartlett, PD Stanton, JR Reeves, TG Cooke
Breast Cancer Research 6 (3), 1-6, 2004
Is PTEN loss associated with clinical outcome measures in human prostate cancer?
P McCall, CJ Witton, S Grimsley, KV Nielsen, J Edwards
British journal of cancer 99 (8), 1296-1301, 2008
Can molecular markers predict when to implement treatment with aromatase inhibitors in invasive breast cancer?
S Tovey, B Dunne, CJ Witton, A Forsyth, TG Cooke, JMS Bartlett
Clinical cancer research 11 (13), 4835-4842, 2005
Cyclooxygenase 2 (COX2) expression is associated with poor outcome in ER‐negative, but not ER‐positive, breast cancer
CJ Witton, SJK Hawe, TG Cooke, JMS Bartlett
Histopathology 45 (1), 47-54, 2004
Molecular alterations in AKT1, AKT2 and AKT3 detected in breast and prostatic cancer by FISH
T Kirkegaard, CJ Witton, J Edwards, KV Nielsen, LB Jensen, ...
Histopathology 56 (2), 203-211, 2010
A Multi-Centre Investigation Towards Reaching a Consensus on the Immunohistochemical Detection of ERβ in Archival Formalin-fixed Paraffin Embedded Human Breast Tissue
PJ Carder, CE Murphy, P Dervan, M Kennedy, A McCann, PTK Saunders, ...
Breast cancer research and treatment 92 (3), 287-293, 2005
HER4 in breast cancer: comparison of antibodies against intra-and extra-cellular domains of HER4
SM Tovey, B Dunne, CJ Witton, TG Cooke, JMS Bartlett
Breast cancer research 8 (2), R19, 2006
Frequent amplifications and deletions of G 1/S-phase transition genes, CCND1 and MYC in early breast cancers: a potential role in G 1/S escape
LB Jensen, JMS Bartlett, CJ Witton, T Kirkegaard, S Brown, S Müller, ...
Cancer Biomarkers 5 (1), 41-49, 2009
Tavassoli FA, Devilee P: Pathology and Genetics: Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours series-volume IV. Lyon, France: IARC Press
AM Hanby
Breast Cancer Research 6 (3), 1-2, 2004
Structure of HER receptors and intracellular localisation of downstream effector elements gives insight into mechanism of tumour growth promotion
CJ Witton
Breast Cancer Research 5 (4), 206, 2003
Determining sensitivity to rapamycin and its analogues in breast cancer patients
CJ Witton
Breast Cancer Research 7 (1), 1-2, 2004
Injection of a boar sperm factor causes calcium oscillations in oocytes of the marsupial opossum, Monodelphis domestica
CJ Witton, K Swann, J Carroll, HDM Moore
Zygote 7 (4), 271-277, 1999
Coexpression of EGFr, HER2, HER3 and HER4 in primary human breast carcinoma
CJ Witton, JR Reeves, JG Going, TG Cooke, JMS Bartlett
European Journal of Cancer 37, 21-22, 2001
Predictive gene expression profile of breast cancer patients treated with tamoxifen
MB Lyng, AV Lænkholm, W Vach, N Pallisgaard, A Knoop, H Ditzel
San Antonio Breast Cancer Symposium 2007, 2007
8th Nottingham International Breast Cancer Conference, Nottingham, UK, 16–19 September 2003
JL Limer, AT Parkes, A Waterworth, CE Murphy, CR Tait, CJ Witton
Breast Cancer Research 6 (1), E1, 2003
Analysis of HER2 status in breast cancer: a multicentre comparison of automated image analysis systems versus manual assessment.
J Bartlett, I Ellis, E Mallon, C Paish, R A'Hern, T Cooke, J Salter, C Witton, ...
Breast Cancer Research and Treatment 69 (3), 2001
Abstract# 638: Secretory phospholipase A2-degradable liposomal formulations of cisplatin and oxaliplatin: Pre-clinical results
F Melander, M Leeman, A Vikbjerg, M Petersen, H Lykkegaard, C Witton, ...
Cancer Research 69 (9 Supplement), 638-638, 2009
The system can't perform the operation now. Try again later.
Articles 1–20